USE OF INTEGRIN BLOCKADE TO INHIBIT CD8+ MEMORY T CELLS IN SOLID ORGAN TRANSPLANTATION Pubblico
Haridas, Divya (2011)
Abstract
ABSTRACT
USE OF INTEGRIN BLOCKADE TO INHIBIT CD8+ T CELLS IN
SOLID
ORGAN TRANSPLANTATION
By: Divya Haridas
Although calcineurin-based inhibitors have come a long way in
inhibiting organ
rejection, the associated toxicities have led to the continued
quest for better
immunosuppressants. Two potential candidates are belatacept and
efalizumab. Belatacept
is a costimulation blocker that has been shown to have higher acute
rejection rates in
kidney transplant patients compared to traditional calcineurin
inhibitors. Here we
hypothesize and show that belatacept had no effect on the cytokine
production of
memory CD8+ T cells. Efalizumab binds the integrin LFA-1 and blocks
the LFA-1-
ICAM-1 interaction crucial for T cell activation and trafficking.
We show here that
efalizumab was effective in inhibiting alloreactive memory CD8 T
cell responses. We
also found that graft-elicited CD8+ T cells were inhibited by
anti-LFA-1 but not
pathogen-elicited T cells. Thus, the susceptibility of T cells to
different
immunosuppressants is different based on their priming conditions
and this warrants
further investigation.
Table of Contents
Introduction 1
Types of Graft Rejection 1
History of Immunosuppression 2
Important Immunosuppressive Drugs And Their Side Effects 2
Development and Efficacy of Belatacept 3
Methods 6
Results 7
Discussion 10
Figures 12
References 21
About this Master's Thesis
School | |
---|---|
Department | |
Degree | |
Submission | |
Language |
|
Research Field | |
Parola chiave | |
Committee Chair / Thesis Advisor | |
Committee Members |
Primary PDF
Thumbnail | Title | Date Uploaded | Actions |
---|---|---|---|
USE OF INTEGRIN BLOCKADE TO INHIBIT CD8+ MEMORY T CELLS IN SOLID ORGAN TRANSPLANTATION () | 2018-08-28 10:20:11 -0400 |
|
Supplemental Files
Thumbnail | Title | Date Uploaded | Actions |
---|